Chronic Malignancies Working Party (CMWP)
Lymphoma Working Party (LWP)
Study type:
Study number:
42206644
Type of treatment:
Diseases:
Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)
Short title:
CALM
Primary objective:
Key inclusion criteria:
MM or LLymphoma; >18 years old; auto tx; mobilization including Periflaxor label indication
Country:
Principal investigator:
Curly Morris, Anna Sureda
EBMT Study coordinator:
Paul Bosman, Cora Knol-Bout, Steffie van der Werf